Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1988 Jul;43(7):578–579. doi: 10.1136/thx.43.7.578

Angiotropic large cell lymphoma presenting as interstitial lung disease.

T B Tan 1, P J Spaander 1, M Blaisse 1, F M Gerritzen 1
PMCID: PMC461383  PMID: 3212758

Abstract

A case of angiotropic large cell lymphoma is reported in which the patient presented with only pulmonary symptoms. It suggests that this rare and highly malignant lymphoma should be considered in the differential diagnosis of interstitial lung disease, and shows the value of open lung biopsy in unexplained interstitial lung disease. This patient responded well to treatment with cyclophosphamide, doxorubicin, vincristine, and prednisone.

Full text

PDF
578

Images in this article

578Image
on p.578
579Image
on p.579

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ansell J., Bhawan J., Cohen S., Sullivan J., Sherman D. Histiocytic lymphoma and malignant angioendotheliomatosis: one disease or two? Cancer. 1982 Oct 15;50(8):1506–1512. doi: 10.1002/1097-0142(19821015)50:8<1506::aid-cncr2820500810>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  2. Carroll T. J., Jr, Schelper R. L., Goeken J. A., Kemp J. D. Neoplastic angioendotheliomatosis: immunopathologic and morphologic evidence for intravascular malignant lymphomatosis. Am J Clin Pathol. 1986 Feb;85(2):169–175. doi: 10.1093/ajcp/85.2.169. [DOI] [PubMed] [Google Scholar]
  3. Gupta A. K., Lipa M., Haberman H. F. Proliferating angioendotheliomatosis. Case with long survival and review of literature. Arch Dermatol. 1986 Mar;122(3):314–319. doi: 10.1001/archderm.122.3.314. [DOI] [PubMed] [Google Scholar]
  4. Keahey T. M., Guerry D., 4th, Tuthill R. J., Bondi E. E. Malignant angioendotheliomatosis proliferans treated with doxorubicin. Arch Dermatol. 1982 Jul;118(7):512–514. [PubMed] [Google Scholar]
  5. Mori S., Itoyama S., Mohri N., Shibuya A., Hirose T., Takanashi R., Oshimi K., Mizoguchi H., Epstein A. E. Cellular characteristics of neoplastic angioendotheliosis. An immunohistological marker study of 6 cases. Virchows Arch A Pathol Anat Histopathol. 1985;407(2):167–175. doi: 10.1007/BF00737074. [DOI] [PubMed] [Google Scholar]
  6. PFLEGER L., TAPPEINER J. [On the recognition of systematized endotheliomatosis of the cutaneous blood vessels (reticuloendotheliosis?]. Hautarzt. 1959 Aug;10:359–363. [PubMed] [Google Scholar]
  7. Schlingemann R. O., Dingjan G. M., Emeis J. J., Blok J., Warnaar S. O., Ruiter D. J. Monoclonal antibody PAL-E specific for endothelium. Lab Invest. 1985 Jan;52(1):71–76. [PubMed] [Google Scholar]
  8. Sheibani K., Battifora H., Winberg C. D., Burke J. S., Ben-Ezra J., Ellinger G. M., Quigley N. J., Fernandez B. B., Morrow D., Rappaport H. Further evidence that "malignant angioendotheliomatosis" is an angiotropic large-cell lymphoma. N Engl J Med. 1986 Apr 10;314(15):943–948. doi: 10.1056/NEJM198604103141502. [DOI] [PubMed] [Google Scholar]
  9. Wick M. R., Banks P. M., McDonald T. J. Angioendotheliomatosis of the nose with fatal systemic dissemination. Cancer. 1981 Dec 1;48(11):2510–2517. doi: 10.1002/1097-0142(19811201)48:11<2510::aid-cncr2820481128>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES